This document provides a review of literature on age-related cardiopulmonary changes. It summarizes research showing that aging leads to structural and functional changes in both the cardiovascular and respiratory systems. For the cardiovascular system, changes include increased stiffness of arteries and valves, decreased compliance of heart walls, and alterations in the electrical conduction system. For the respiratory system, aging causes a loss of elastic recoil in the lungs, decreased compliance of the chest wall and ventilatory muscles, and a decline in both diffusion capacity and maximal aerobic power. The integration of cardiovascular and pulmonary systems during exercise is also impacted by aging.
physiotherapy management for chronic obstructive pulmonary disease Sunil kumar
role of physiotherapy in chronic obstructive pulmonary disease, principles of physical therapy management in copd, physiotherapy assessing and treatment for copd
physiotherapy management for chronic obstructive pulmonary disease Sunil kumar
role of physiotherapy in chronic obstructive pulmonary disease, principles of physical therapy management in copd, physiotherapy assessing and treatment for copd
Exercise Prescription for Cardiac Patientsnihal Ashraf
Cardiovascular disease (CVD) is the leading cause of death and a major cause of disability worldwide. (WHO., 2003)
Cardiac rehabilitation is the process of restoring psychological, physical and social function in the people with manifestations of coronary artery disease( CAD).
This PPT is prepared for the basic understanding of third year physiotherapy students in the field of ICF. It describes the reasons for use of ICF, basic terminology and its meanings, relationship between different domains of ICF with relevant clinical examples.
این پاورپوینت در کارگاه عملی ارزیابی و توانبخشی مشکلات راه رفتن در کودکان فلج مغزی دکتر خیاط زاده ارائه شده است. برای مطالعه مطالب بیشتر در این زمینه به وب سایت فروردین مراجعه کنید.
WWW.FARVARDIN-GROUP.COM
CYSTIC FIBROSIS AND PHYSIOTHERAPY TREATMENT.pptxShilpasree Saha
Physiotherapy has long been considered a cornerstone of condition management for
people with cystic fibrosis (CF). The presentation of CF has changed over time with an increased
life expectancy and increased expectations of people with CF to have a complete lifestyle.
Exercise Prescription for Cardiac Patientsnihal Ashraf
Cardiovascular disease (CVD) is the leading cause of death and a major cause of disability worldwide. (WHO., 2003)
Cardiac rehabilitation is the process of restoring psychological, physical and social function in the people with manifestations of coronary artery disease( CAD).
This PPT is prepared for the basic understanding of third year physiotherapy students in the field of ICF. It describes the reasons for use of ICF, basic terminology and its meanings, relationship between different domains of ICF with relevant clinical examples.
این پاورپوینت در کارگاه عملی ارزیابی و توانبخشی مشکلات راه رفتن در کودکان فلج مغزی دکتر خیاط زاده ارائه شده است. برای مطالعه مطالب بیشتر در این زمینه به وب سایت فروردین مراجعه کنید.
WWW.FARVARDIN-GROUP.COM
CYSTIC FIBROSIS AND PHYSIOTHERAPY TREATMENT.pptxShilpasree Saha
Physiotherapy has long been considered a cornerstone of condition management for
people with cystic fibrosis (CF). The presentation of CF has changed over time with an increased
life expectancy and increased expectations of people with CF to have a complete lifestyle.
Age-Related Physiological Changes and Their Clinical SignificanceTrading Game Pty Ltd
Physiological changes occur with aging in all organ systems. The cardiac output decreases, blood pressure increases and arteriosclerosis develops. The lungs show impaired gas exchange, a decrease in vital capacity and slower
expiratory flow rates. The creatinine clearance decreases with age although the serum creatinine level remains relatively constant due to a proportionate age-related decrease in creatinine production. Functional'changes, largely
related to altered motility patterns, occur in the gastrointestinal system with senescence, and atrophic gastritis and altered hepatic drug metabolism are common in the elderly. Progressive elevation of blood glucose occurs with age on a multifactorial basis and osteoporosis is frequently seen due 'to a linear
decline in bone mass after the fourth decade. The epidermis of the skin atrophies with age and due to changes in collagen and elastin the skin loses its tone and elasticity. Lean body mass declines with ag'e and this is primarily due to loss and atrophy of muscle cells. Degenerative changes occur in many
joints and this, combined with the loss of muscle mass, inhibits elderly patients locomotion. These changes with age have important practical implications for the clinical management of elderly patients: metabolism is altered, changes
in response to commonly used drugs make different drug dosages necessary and there is need for rational preventive programs of diet and exercise in an effort to delay or reverse some of these changes.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
3. CONTENTS
Ageing and theories of ageing
Cardiovascular changes related to age
Pulmonary changes related to age
Biomechanical changes
Changes in Defense mechanism
Evidence
References
4. AGEING
Ageing: showing the effects of time; a process of change,
usually gradual and spontaneous.
Biological Aging: Aging includes several different kinds of
changes. Age associated changes that involve the physical
structures and functioning of the body and that affect a
person's ability to function or survive are referred to as
biological aging.
Senescence: the loss of power of cell division and growth
and function with time, leading to death.
5. THEORIES OF AGEING
Programmed theories The damage or error theory
1. Programmed longetivity
2. Endocrine theory
3. Immunological theory
1. Wear and tear theory
2. Rate of living theory
3. Cross linking theory
4. Free radicals theory
6. CARDIOVASCULAR CHANGES
Structural changes with aging involve myocardium, the
cardiac conduction system, and endocardium.
There is progressive degeneration of cardiac structure with
ageing that includes loss of elasticity, fibrotic changes in
the valves of heart, and infiltration with myeloid.
7. HEART MASS AND MYOCYTES
Heart mass
Myocyte size
Ventricular thickness
Collagen content
Collagen present at
pericardium becomes
stiffer thus decreasing
cardiac compliance.
(Courtesy: Netter’s atlas of anatomy)
8. MYOCARDIAL SUB CELLULAR
CHANGES
Nucleus becomes larger.
Nucleoli increase in size and number.
Chromatin shows clumping, shrinking, fragmentation or
dissolution.
Mitochondria shows alteration in size shape, crystal
pattern and matrix density.
Cytoplasm is marked by increased fatty infiltration.
Clinical significance
Decreased cellular activities such as homeostasis, protein
synthesis, and degradation rates.
10. VALVES
Valvular circumference
Valvular incompetence
The cusps and leaflets
Clinical significance
Valvular stenosis and mitral valve insufficiency.
Clinical heart murmurs can be detected.
11. CARDIAC MUSCLE COMPLIANCE
Walls of heart becomes less complaint with age.
Decreased wall expansion of left ventricle during diastole
Delayed filling of heart
Decreased cardiac output during systole
12. Age related structural changes in blood
vessels
1. ARTERIES
Decreased dispensability
and elastic recoil of
blood vessels.
Also leads to chronic or
residual increase in
vessel diameter and
vessel wall rigidity
which impair the
function of the vessel.
13. A. Aorta
Wall of aorta becomes less flexible,..
decrease in elastin fiber and increase in collagen
fiber.
Volume elasticity is decreased.
B. Peripheral arteries
Peripheral arteries become stiffer and increase in
diameter.
Accommodation to larger blood volume is altered.
Impedance of blood flow increases.
14. VEINS
Walls becomes thicker due to deposition of
connective tissues and calcium.
Valves of veins becomes stiff and incompetent.
15. CLINICAL SIGNIFICANCE
Rise of systolic pressure and widening of pulse
pressure.
increased ventricular systolic pressure and
decreased aortic diastolic pressure.
Increase in after load.
Limit the maximal perfusion of tissues.
16. BLOOD
Blood appears rather resistant to ageing process.
However the amount of red bone marrow
decreases with age so the capability of formation
of decreases.
17. Age related changes in the electrical
conduction system of the heart
Decrease in number of pacemaker cells at sinoatrial
node with age.
Accumulation of fat.
Calcification of left side of cardiac skeleton.
Changes in electrocardiogram with advancing age.
18. Physiological changes of Heart
1. Heart rate
Supine heart rate is unaffected but sitting heart rate is
decreased.
2. Stroke volume
It remains unaffected.
3. Cardiac output(CO=HR * SV)
Unaffected at rest. However during exercise maximum
cardiac output and aerobic capacity is reduced.
19. 4. Resting blood pressure
Resting blood pressure is not affected by the advancing
age.
It may increase if total peripheral resistance increases
which can be due to narrowing of arteries.
Systolic and diastolic blood pressure tend to rise.
20. 5. Changes in cellular calcium handling:
Affected by increased production of reactive oxygen
species which depends upon the amount of
polyunsaturated fatty acids that decreases with age.
Leads to arrhythmia.
6. Cardiac adrenergic responsiveness:
With age there is diminishment of autonomic
modulation of heart.
There is decrement of cardiovascular response to beta
adrenergic signaling.
21. EVIDENCE
TITLE AND AUTHOR CONCLUSION
1. Aging-associated
cardiovascular changes
and their relationship to
heart failure.
James B. Strait and Edward
G. Lakatta
Aging results in an increase in
cardiovascular disease and a
decrease in cardiac reserve at
the same time that the repair
processes designed to deal
with these problems become
less active/effective.
22. Age related cardiovascular changes
during exercise
Heart rate and exercise
Stroke volume and exercise
Cardiac output
23. Maximal aerobic power
VO2 max is used to determine maximal aerobic
capacity of an individual which decreases with age.`
24. RESPIRATORY CHANGES
Physiological function of ventilation can be defined as
the activity performed by the biomechanical action of
the ventilatory muscles on the anatomically elliptical
thoracic cage to achieve the intrathoracic pressure
changes required for gas flow.
25. Alterations in ventilatory muscles
Both endurance and strength is decreased with age.
Elastic recoil of ventilatory muscle is affected due to
age.
26. AIRWAY/LUNG ALTERATIONS
Elastin fibers in alveoli.
The ducts and Alveolar openings are dilated.
Deposition of Granular black pigment.
There is loss of elastic recoil of the lung.
Proportional decline in vital capacity and residual volume
increases.
27. Thoracic pump alterations
The anatomical changes in thoracic skeleton leads to
more rigid chest wall frame and reduction in mobility.
Reduction of mobility can be first due to increase in
cross-linking of collagen fibers in both ribs and
connecting sternal cartilage and second due to change
in vertebral column.
There is increased lung compliance but decreased
chest wall compliance.
28. Ventilatory Work of Breathing
Although increased RV and FRC provides
mechanical advantage but it leads to altered
positioning of diaphragm(flattened diaphragm).
The total VO2 consumption increases from 1% to
10% to perform work of breathing.
29. Oxygen uptake and delivery
alterations with age
Ventilation and perfusion matching
Gas exchange alteration with ageing
Diffusion
Oxygen delivery
Cellular oxygen uptake
30. Gas exchange alteration with ageing
There is decline in PaO2 that can be expressed as
PaO2=100.1-o.323(age)
As the supporting framework for the alveolar
structures breaks down, the resultant lung collapse
produces both uneven ventilation and uneven
circulation.
Greater at bases than apical region of lungs.
No any effect on arterial carbon dioxide.
31. DIFFUSION
With advancing age, the progressive breakdown of
alveolar and capillary walls and consequential
reduction in alveolar capillary surface area results in
reduced diffusing capacity.
32. OXYGEN DELIVERY
With age the oxygen demand of ventilatory muscles
increases thereby reducing the oxygen availability to
other skeletal muscles.
33. Cellular Oxygen uptake
Dependent on capillary beds and levels of aerobic
enzymes which decreases with age.
There is a decline in a-vO2 difference at skeletal
muscle.
35. Vt and SV increases steadily in response to
progressive oxygen demand up to approximately
50% of VO2 max
Beyond that each system relies on increase on
HR and RR
Steady state is achieved by each system once
oxygen supply meets the demand
36. EVIDENCE
TITLE AND AUTHOR CONCLUSION
Effect of aging on respiratory
system physiology and
immunology.
Gulshan Sharma, James
Goodwin
Aging is associated with
reduction in chest wall
compliance and increased air
trapping. The decline in
FEV1 with age likely has a
nonlinear phase with
acceleration in rate of decline
after age 70 years. (
MEN>WOMEN)
37. BIOMECHANICAL CHANGES
Sternum: the lower end of sternum curves inwards
making upper part of body and manubrium protrude
anteriorly.
Thoracic spine: Reduced height of vertebral bodies,
reduced intervertebral spaces.
Ribs: Ribs tend to appear horizontal position and costal
cartilages becomes calcified.
Joints: Many of the articulations undergoes of fibrosis
which leads to overall decrease in chest wall compliance.
38. EVIDENCE
TITLE AND AUTHOR CONCLUSION
Age-Related Changes in
Stiffness in Human Ribs
Amanda M. Agnew, Yun-
Seok Kang
Fractures were most
commonly located in the
anterolateral region of the
ribs. The current study shows
a distinct trend for stiffness
with increasing age
39. CHANGES IN DEFENSE
MECHANISM
Can be divided into reflex and non reflex processes.
Reflex processes includes apnoetic reflex, sneezing,
aspiration reflex, cough reflex and mucocilliary
transport.
Non reflex processes consists of:
1. Physical defense process created by air-conditioning
system, aerodynamic system, electrostatic filter
2. Chemical defense: based on buffering ability of airway
surface liquid.
3. Cellular defense
40. EVIDENCE
TITLE AND AUTHOR CONCLUSION
2. Age related pulmonary
changes and its relation with
pneumonia.
Keith C. Meyer
Gradual decline in cellular
and humoral components of
immunity leads to increased
rate of pneumonia in
individuals with 65 years of
age or older.
41. REFERENCES
1. A. Guccione. Geriatric physical therapy, second edition.
Mosby: 2000.
2. John E hall. Textbook of medical physiology. Thirteenth
edition. Elsevier: 2016.
3. William D. McArdle. Exercise physiology. Seventh
edition. Lippincott and williams and wilkins. 2010.
4. Strait JB, Lakatta EG. Aging-associated cardiovascular
changes and their relationship to heart failure. Heart
failure clinics. 2012 Jan 1;8(1):143-64.
5. Lesauskaite V, Ebejer MJ. Age-related changes in the
respiratory system. Maltese Med. J.. 1999;11(1.2):25-30.
42. 6.Joshua AL, Shetty LA, Pare VI. Variations in dimensions
and shape of thoracic cage with aging: an anatomical
review. Anatomy Journal of Africa. 2014;3(2):346-55.
7. Sharma G, Goodwin J. Effect of aging on respiratory
system physiology and immunology. Clinical interventions
in aging. 2006 Sep;1(3):253.
8. Korpáš J, Honda Y. Aspects of airway defence
mechanisms. Pathophysiology. 1996 May 1;3(2):81-6.